Daniel S. Levine

Daniel S. Levine is editor of Rare Daily. You can contact him by sending email to editor@globalgenes.org

Rare Leader: Taylor Kane, Founder and CEO, Remember the Girls
The Basics Name:  Taylor Kane Title: Founder and CEO Organization: Remember the Girls Disease focus:  Carriers of X-linked recessive… Continue Reading
Gene Responsible for Screw Tail in Dogs Linked to Rare Human Disease
Rare Daily Staff Researchers at the University of California Davis have found a genetic connection between so-called screwtail breed dogs… Continue Reading
CANbridge Pharmaceuticals and WuXi Biologics Expand Partnership
Rare Daily Staff CANbridge Pharmaceuticals and WuXi Biologics said they are expanding their rare disease partnership to enable CANbridge to… Continue Reading
The Significant Deals Ahead This Year
At the annual J.P. Morgan Healthcare Conference in San Francisco and the shadow conferences that take place alongside it, the biotech… Continue Reading
Apic Bio Completes $40 Million Financing to Advance Gene Therapies
Rare Daily Staff Apic Bio said it completed a $40 million financing to advance its experimental gene therapy programs and support additional… Continue Reading
Ultragenyx Reports Positive Results from First Cohort of Phase 1/2 Study Glycogen Storage Disease Gene Therapy
Rare Daily Staff Ultragenyx Pharmaceutical reported positive topline safety and efficacy data from the first, lowest dose cohort of its… Continue Reading
Viela Bio Reports Positive Results in NMOSD Trial
Rare Daily Staff Viela Bio reported that a pivotal trial of its experimental drug inebilizumab met its primary and key secondary endpoints… Continue Reading
be-a-guest-blogger

Follow us on Twitter